Skip to main content

Year: 2021

Insulated Gate Bipolar Transistor Market Data Current and Future Trends, Industry Size, Share, Revenue, Business Growth Forecast to 2028, Fortune Business Insights

Companied Profiled in IGBT Market Are Infineon Technologies AG (Munich, Germany), Danios Group (Nordberg, Denmark), ROHM CO., LTD (Kyoto, Japan), Hitachi, Ltd. (Tokyo, Japan), ABB Ltd (Zürich, Switzerland), Mitsubishi Electric Corporation (Tokyo, Japan), Fuji Electric Co., Ltd. (Tokyo, Japan), Toshiba Corporation (Tokyo, Japan), LITTELFUSE, INC. (Illinois, United States), Star Power Semiconductor Ltd. (Jinxing, China). Pune, India, Dec. 08, 2021 (GLOBE NEWSWIRE) — The global Insulated Gate Bipolar Transistor Market size is expected to reach USD 11.24 billion by 2028, exhibiting a CAGR of 9.8% during the forecast period. The increasing demand for IGBT from high voltage applications such as motor drive inverters, solar inverters, uninterruptible power supplies (UPS), and others will boost the market growth. As per a report by Fortune...

Continue reading

Connected Agriculture Market Research Report: Industry Analysis, Segmentation, Share, Size, Opportunities and Forecast to 2026, Fortune Business Insights

Companies Covered in Connected Agriculture Market Research Report are IBM Corporation, Microsoft, Cisco Systems Inc., Iteris Inc. Trimble Inc., Ag Leader Technology, Decisive Farming, GAMAYA, SWIIM System, Ltd., Orange Business Services, LINK LABS. Pune, India, Dec. 08, 2021 (GLOBE NEWSWIRE) — The global Connected Agriculture Market size is projected to reach USD 7.22 billion by the end of 2026. The demand for smart water management will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Connected Agriculture Market Size, Share & Industry Analysis, By Component (Solutions, Services), By Application (Pre-Production Management, In-Production Management, Post-Production Management) and Regional Forecast, 2019-2026,” the market was worth USD 1.84 billion in 2018...

Continue reading

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 10 million sales milestone payment to Basilea

Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 08, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced today that sales of the antifungal Cresemba® (isavuconazole) by its partner Pfizer in Europe, Russia and Israel exceeded the threshold triggering a milestone payment to Basilea of USD 10 million. This is the second sales milestone payment by Pfizer in 2021. David Veitch, Chief Executive Officer of Basilea, said: “The second 10 million U.S. dollar sales milestone payment by our partner Pfizer, within less than twelve months, confirms that the need for Cresemba continues to increase rapidly. Together with our partners, we at Basilea are determined to make Cresemba available to increasing...

Continue reading

Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock

MENLO PARK, Calif. and BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer and other diseases, today announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a public offering price of $14.00 per share. Adicet also granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $87.5 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares in the...

Continue reading

The Kingdom of Denmark will issue a green bond in 2022

On 19 January 2022, the Kingdom of Denmark will open a green bond with a coupon rate of 0.00 per cent and maturity on 15 November 2031. The opening is contingent on stable market conditions. The green bond will be opened via auction in line with the Kingdom of Denmark’s other domestic bonds. The expected issuance volume will be announced in connection with the announcement of the central government’s borrowing strategy in December. The issuance volume of green bonds is determined on the basis of the amount of eligible green expenditures, which constitutes an upper ceiling, while taking the overall borrowing strategy into account. “The market for green bonds and green financing has grown significantly in recent years. I am pleased that Danmarks Nationalbank can contribute to supporting the development of the green capital...

Continue reading

Beter Bed opens first Sleep Experience

Sleep specialist Beter Bed has officially opened its first experience store at Sontplein in Groningen, the Netherlands. The opening of the experience store is in line with the strategy presented earlier this year to solidify its brick–and–mortar base by adding new store formats into its current store format portfolio. The new sleep experience store format is packed with innovation and provides customers with tailored sleep advice in order to sleep better and as a result wake up healthier, happier and more productive. John Kruijssen, CEO of Beter Bed Holding N.V. is proud to present the new store format: “This new experience store is the embodiment of our recently launched strategy towards 2025, and sets the standard for rollout to our current store network. The store is a breeding ground for experimentation in how we present...

Continue reading

Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001

Saint-Herblain (France), December 8, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the Company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured for VLA2001 since reporting positive data for its Phase 3 clinical trial Cov-Compare. Valneva has initiated a rolling submission process with the Bahraini National Health Regulatory Authority (NHRA). Franck Grimaud, Chief Business Officer of Valneva, commented, “We are grateful to the Bahraini government for their trust and confidence in our vaccine and are eager to work with them to start helping to address the pandemic evolution in the Middle-East. Subject to regulatory review...

Continue reading

WISeKey’s CEO, Carlos Moreira, to Present the Company’s Unique NFT Technologies at the Imperial Capital Security Investor Conference on December 15

WISeKey’s CEO, Carlos Moreira, to Present the Company’s Unique NFT Technologies at the Imperial Capital Security Investor Conference on December 15 Geneva – December 8, 2021 – WISeKey International Holding Ltd. (“WISeKey,” SIX: WIHN / Nasdaq: WKEY), a leading global Semi-conductor, AI and IoT company, today announced that its CEO, Carlos Moreira will present at the Imperial Capital Security Investor Conference on Wednesday, December 15, 2021, at the InterContinental New York Barclay. WISeKey’s main presentation is scheduled for 10:30 am ET. WISeKey’s presentation will focus on the new NFT blockchain technology of its WISe.ART Marketplace showcased during the International Art Week – Art Basel Miami. The WISe.ART Marketplace has received international attention and will gradually include and auction historical art pieces, documents/letters...

Continue reading

Cingulate Inc. Announces Pricing of $25.0 Million Initial Public Offering

KANSAS CITY, Kan., Dec. 07, 2021 (GLOBE NEWSWIRE) — Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation products, today announced the pricing of its initial public offering of 4,166,666 shares of common stock and accompanying warrants to purchase 4,166,666 shares of common stock. Each share of common stock is being sold together with one warrant to purchase one share of common stock with an exercise price of $6.00 at a combined public offering price of $6.00 per share and accompanying warrant. All of the shares and warrants are being offered by Cingulate. The Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional...

Continue reading

Imperial Acquires Mineral Claims Expanding its Sustut Property

VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”), has acquired four mineral claims totalling 6,834.47 hectares from Freeport-McMoRan Mineral Properties Canada Inc. for the consideration of claim assessment work expenditures and a 0.5% Net Smelter Return royalty. The acquired claims are contiguous with the Company’s Sustut property which is held by Selkirk Metals Corp. (“Selkirk”), a wholly owned subsidiary. It is located in northcentral British Columbia, approximately 40 kilometres south of the Kemess Mine. The newly acquired claims cover two Minfile occurrences, the A Bornite (094D 038) and A Chalcocite (094D057) which consist of fracture-controlled copper-silver mineralization of bornite and chalcocite hosted in the Upper Triassic Savage Mountain Formation, the same host...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.